SAN FRANCISCO, Nov. 19 - Exelixis has agreed to acquire Genomica for a stock-for-stock transaction valued at $110 million, the companies announced on Monday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.
A BMJ study says that about half of former hematology-oncology regulators now work for industry.
Science should wish PhDs who leave academia well, a Nature editorial says.
New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.